開創國際(600097.SH):大連隆泰及其一致行動人已通過集中競價減持1.83%的股份
格隆匯5月11日丨開創國際(600097.SH)公佈,2019年11月12日至2020年5月10日,大連隆泰及其一致行動人通過集中競價方式累計減持公司股份441.7695萬股,佔公司總股本1.83%,其中大連隆泰減持235萬股,北方信託減持206.7695萬股。
此次減持屆滿後,大連隆泰持有公司股份205萬股,佔公司總股本0.85%;大連隆泰通過北方國際信託股份有限公司下設的北方信託元寶34號單一資金信託持有公司股份560.0036萬股,佔公司總股本比例2.32%。至此,大連隆泰及其一致行動人合計持有公司股份765.0036萬股,合計佔公司總股本比例3.17%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.